| Literature DB >> 32408715 |
Ruxandra Ștefănescu1, Amelia Tero-Vescan2, Ancuța Negroiu1, Elena Aurică1, Camil-Eugen Vari3.
Abstract
The general spread of Tribulus terrestris L. (South Africa, Australia, Europe, and India), the high content of active ingredients (in particular sterol saponins, as well as flavonoids, tannins, terpenoids, phenol carboxylic acids, and alkaloids), and its frequent uses in folk medicine, and as food supplements highlight the importance of evaluating its phytopharmacological properties. There are miscellaneous hypotheses that the species could have a high potential for the prevention and improvement of various human conditions such as infertility, low sexual desire, diabetes, and inflammatory diseases. Worldwide, numerous herbal supplements are commercialized with indications mostly to improve libido, sexual performance in both sexes, and athletic performance. Phytochemical studies have shown great disparities in the content of active substances (in particular the concentration of furostanol and spirostanol saponoside, considered to be the predominant active ingredients related to the therapeutic action). Thus, studies of experimental pharmacology (in vitro studies and animal models in vivo) and clinical pharmacology (efficacy and safety clinical trials) have sometimes led to divergent results; moreover, the presumed pharmacodynamic mechanisms have yet to be confirmed by molecular biology studies. Given the differences observed in the composition, the plant organ used to obtain the extract, the need for selective extraction methods which are targeted at the class of phytocompounds, and the standardization of T. terrestris extracts is an absolute necessity. This review aims to highlight the phytochemical, pharmacological, and toxicological properties of T. terrestris, with a focus on the contradictory results obtained by the studies conducted worldwide.Entities:
Keywords: Tribulus terrestris; phytopharmacology; saponosides
Mesh:
Substances:
Year: 2020 PMID: 32408715 PMCID: PMC7277861 DOI: 10.3390/biom10050752
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Previous reviews.
| Year of the Review | Main Topic | Years Surveyed | Limitations | Reference |
|---|---|---|---|---|
| 2005 | Phytochemistry and pharmacology | <2004 | [ | |
| 2014 | TT supplements | NS | [ | |
| 2014 | Phytochemistry and pharmacology | short review | [ | |
| 2014 | Phytochemistry and pharmacology | NS | short review | [ |
| 2016 | Analysis of human and animal evidence | 1968–2015 | [ | |
| 2016 | Phytochemistry | NS | Only the composition of fruits was discussed | [ |
| 2016 | Phytochemistry and pharmacology | NS | [ | |
| 2017 | Phytochemistry and pharmacology | NS | [ | |
| 2018 | Male infertility | short review | [ | |
| 2019 | Phytochemistry and ethnomedicine | NS | brief presentation of constituents | [ |
| 2019 | Male infertility | NS | [ | |
| 2019 | Phytochemistry and pharmacology | 1965–2017 | [ | |
| 2020 | Phytochemistry and pharmacology | NS | the review is based mostly on Ayurvedic preparation | [ |
NS, not specified.
Figure 1Spirostanol (left) and furostanol (right) saponins.
Chemical compounds identified in Tribulus terrestris (TT).
| Compound | Chemical Formula | Plant Part | Conc. mg/100 g | Plant Origin | References |
|---|---|---|---|---|---|
|
| |||||
| Protodioscin | C51H84O22 | aerial parts | 109–1530 | Bulgaria | [ |
| leaves | 1000–1330 | ||||
| stem | 19–27 | ||||
| fruits | 240–500 | ||||
| aerial parts | 340–1000 | Turkey | [ | ||
| fruits | 10–60 | ||||
| aerial parts | 220–790 | Greece | [ | ||
| aerial parts | 420–990 | Macedonia | [ | ||
| aerial parts | 200 | Serbia | [ | ||
| aerial parts | 560 | Georgia | [ | ||
| aerial parts | 3 | Vietnam | [ | ||
| fruits | 1 | ||||
| fruits | 63–89 | China | [ | ||
| stem | 24 | India | [ | ||
| aerial parts | 190 | Russia | [ | ||
| Neoprotodioscin | C51H86O22 | aerial parts | NS | Bulgaria | [ |
| Prototribestin | C45H73NaO20S | aerial parts | 130–2200 | Bulgaria | [ |
| fruits | 21–28 | ||||
| leaves | 700 | ||||
| stems | 40 | ||||
| aerial parts, | 310–1000 | Turkey | [ | ||
| fruits | 17–65 | ||||
| aerial parts | 220–790 | Greece | [ | ||
| aerial parts | 420–990 | Macedonia | [ | ||
| [ | |||||
| aerial parts | 170 | Serbia | [ | ||
| aerial parts | 240 | Georgia | [ | ||
| Neoprototribestin | C45H75NaO20S | aerial parts | NS | Bulgaria | [ |
| Terestrinin A | C33H48O9 | fruits | NS | China | [ |
| Terestrinin B | C60H95O30 | root | NS | Georgia | [ |
| fruits | NS | China | [ | ||
| Terrestrinin D | C33H50O10 | fruits | 5.6 | China | [ |
| Terestrinin J-T | whole plant | NS | China | [ | |
| Terestroside A | root | NS | Georgia | [ | |
| Terrestrosin K | C51H82O24 | fruits | 1.27 | China | [ |
| Terrestrosin I | C51H84O25 | whole plant | NS | China | [ |
| fruits | |||||
| Tribufuroside D | C45H74O21 | fruits | NS | China | [ |
| Tribufuroside E | C45H74O21 | fruits | NS | China | [ |
| Tribulosaponin A | C51H84O21 | fruits | NS | China | [ |
| Polianthoside D | C56H92O29 | root | NS | Georgia | [ |
| fruits | 59.6 | China | [ | ||
|
| |||||
| Dioscin | C45H72O16 | aerial parts | NS | Egypt | [ |
| aerial parts | 60 | Russia | [ | ||
| fruits, leaves, stem | 10–43 | Bulgaria | [ | ||
| aerial parts | 6–13 | Turkey | [ | ||
| fruits | 1–2 | ||||
| aerial parts | 26–31 | Greece | [ | ||
| aerial parts | 13–15 | Macedonia | [ | ||
| aerial parts | 87 | Serbia | [ | ||
| aerial parts | 8 | Georgia | [ | ||
| Tribestin | C39H61NaO14S | aerial parts | 2–220 | Bulgaria | [ |
| fruits | 0.9–3.4 | ||||
| leaves | 62 | ||||
| aerial parts | 6.8–28 | Turkey | [ | ||
| fruits | 0.5–1 | ||||
| aerial parts | 24 | Greece | [ | ||
| aerial parts | 7.3–10 | Macedonia | [ | ||
| aerial parts | 210 | Serbia | [ | ||
| aerial parts | 6 | Georgia | [ | ||
| Diosgenin | C27H42O3 | NS | NS | China | [ |
| NS | NS | Ukraine | [ | ||
| fruits | 86 | India | [ | ||
| Tribulosin | C55H90O25 | aerial parts | 0.1–7.7 | Bulgaria | [ |
| fruits | 2.6 | ||||
| leaves | 0.8 | ||||
| stem | 1.7 | ||||
| aerial parts | 0.03–1.7 | Turkey | [ | ||
| fruits | 0.14 | ||||
| aerial parts | 1.3–2.4 | Greece | [ | ||
| aerial parts | 0.68 | Macedonia | [ | ||
| aerial parts | 2.24 | Serbia | [ | ||
| aerial parts | 0.56 | Georgia | [ | ||
| aerial parts | 22 | Vietnam | [ | ||
| fruits | 420 | ||||
| fruits | 1 | India | [ | ||
| leaves | 644 | ||||
| stem | 185 | ||||
| whole plant | NS | India | [ | ||
| Tigogenin | C27H44O3 | fruits | 0.05 | China | [ |
| Terestrinin U | whole plant | NS | China | [ | |
| Gitogenin | C27H44O4 | NS | NS | China | [ |
| Hecogenin | C27H42O4 | fruits | NS | Taiwan | [ |
| fruits | 0.4 | China | [ | ||
| Agovoside A | fruits | NS | China | [ | |
| Prosapogenin B | aerial parts | NS | Egypt | [ | |
| 25R-5a-Spirost-3,6,12-trione | C27H39O5 | NS | NS | China | [ |
| 25R-Spirost-4-ene-3,12-dione | C27H40O4 | NS | NS | China | [ |
| 25R-Spirost-4-ene-3,6,12-trione | C27H38O6 | NS | NS | China | [ |
|
| |||||
| Coumaroyltyramine | C17H17NO3 | fruits | NS | Taiwan | [ |
| fruits | NS | China | |||
| Ferulic acid | fruits | NS | Taiwan | [ | |
| Feruloyloctopamine | C18H19NO5 | fruits | NS | China | [ |
|
| |||||
| 5-p-cis-coumaroylquinic acid | C16H18O8 | aerial parts | NS | Egypt | [ |
| 5-p- | aerial parts | NS | Egypt | [ | |
| 4,5-Di-p- | aerial parts | NS | Egypt | [ | |
| 4,5-Di-p- | aerial parts | NS | Egypt | [ | |
|
| |||||
| Tribuloside | C30H26O13 | leaves, fruits | NS | India | [ |
| Kaempferol | C15H10O6 | leaves, fruits | 18 | India | [ |
| Astragalin (kaempferol 3-glucoside) | C21H20O11 | leaves, fruits | NS | India | [ |
| Kaempferol 3-rutinoside | C27H30O15 | leaves, fruits | NS | India | [ |
| Kaempferol-3- gentiobioside | C27H30O16 | fruits leaves | NS | China | [ |
| Rutin | C27H30O16 | leaves | NS | Mauritania | [ |
| fruits, leaves | NS | India | |||
| fruits, leaves | 70–250 | Bulgaria | |||
| fruits | NS | Korea | |||
| NS | NS | Ukraine | [ | ||
| Quercetin | C15H10O7 | fruits, leaves | NS | India | [ |
| Quercetin-3- | C26H28O16 | fruits leaves | NS | China | [ |
| Quercetin-3- | C33H40O21 | leaves | NS | China | [ |
| Quercetin-3- gentiobioside | C27H30O17 | fruits, leaves | NS | China | [ |
| Quercetin 3,7-diglucoside | C27H30O17 | fruits, leaves | NS | China | [ |
| Isoquercitrin | C21H20O12 | fruits, leaves | NS | China | [ |
| Luteolin-7- | C30H18O11 | leaves | NS | China | [ |
| Isorhamnetin-3-glucoside | C22H22O12 | leaves | NS | China | [ |
| Apiotribosides A-D | roots | NS | Georgia | [ | |
|
| |||||
| Harmine | C13H12N2O | fruits | 14 | India | [ |
| fruits, stem, leaves, roots | NS | Turkey | [ | ||
| Harmane | C12H10N2 | fruits, stem, leaves, roots | NS | Turkey | [ |
| aerial parts | NS | Australia | [ | ||
| Harmalol | C12H12N2O | fruits, stem, leaves, roots | NS | Turkey | [ |
| Harmaline | C13H14N2O | stem, leaves, roots | NS | Turkey | [ |
| Norharmane | C11H8N2 | aerial parts | NS | Australia | [ |
| Tribulusterine | C16H12N2O2 | fruits | NS | Taiwan | [ |
| not specified | NS | India | [ | ||
| n-Caffeoyltyramine | fruits | NS | Korea | [ | |
| fruits | China | ||||
| Perlolyrine | C16H12N2O2 | not specified | NS | India | [ |
|
| |||||
| Terrestribisamide | C13 H18NO5 | fruits | NS | Taiwan | [ |
| Tribulusamide A | C36H36N2O8 | fruits | NS | China | [ |
| Tribulusamide B | C36H34N2O9 | fruits | NS | China | [ |
| Tribulusamide D | C17H15NO5 | fruits | NS | Korea | [ |
| Tribulusamide C | C18H15NO6 | fruits | NS | China | [ |
|
| |||||
| Oleic acid | C18H34O2 | stem | NS | Pakistan | [ |
| Palmitic acid | C16H32O2 | stem | NS | Pakistan | [ |
| 6,9,12,15-Docosatetraenoic acid, methyl ester | C23H38O2 | stem | NS | Pakistan | [ |
| Pentadecanoic acid, 14-methyl-, methyl ester | C17H34O2 | stem | NS | Pakistan | [ |
| 9,12-Octadecadienoic acid, methyl ester (E,E)- | C19H34O2 | stem | NS | Pakistan | [ |
|
| |||||
| β-sistosterol-D-glucoside | C35H60O6 | whole plant | NS | India | [ |
| Stigmasterol | C29H48O | stem | NS | Pakistan | [ |
|
| |||||
| ß-1, 5- | C19H18O7 | roots | NS | India | [ |
| 1,3-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester | C24H38O4 | stem | NS | Pakistan | [ |
| Apiol | C12H14O4 | stem | NS | Pakistan | [ |
| Octacosane | C28H58 | stem | NS | Pakistan | [ |
| Heptacosane | C27H56 | stem | NS | Pakistan | [ |
Concentration is expressed in mg/100 g DW (dry weight). NS, not specified or the concentration could not be calculated using the given data in research paper.
Figure 2The most common compounds found in TT extracts.
Figure 3The presumed mechanisms of action responsible for the effects of TT extracts in sexual disorders. GnRH, gonadotropin-releasing hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; ITT, intratesticular testosterone; eNOS, endothelial nitric oxide synthase; NO, nitric oxide; sGC, soluble guanylate cyclase; and cGMP, cyclic guanosine monophosphate.
In vitro and in vivo studies regarding the efficacy of TT extracts in sexual disorders and their design evaluation.
| Herbal Drug and Subjects | Assay/Parameters | Outcome of Treated Group | Study Design Evaluation | Reference |
|---|---|---|---|---|
| In Vitro Studies | ||||
| Organ bath study of the | Relaxation level | Concentration-dependent relaxation response | Part of the plant: NO | Kam et al. (2012) |
| male rabbits | Origin: NO | [ | ||
| Phytochemical analysis: NO | ||||
| Control group: NO | ||||
| Appropriate Statistical analysis: YES | ||||
| Human sperm from 40 healthy volunteers | Motility analysis | Motility ↑ * after 60 minutes of incubation | Part of the plant: NO | Khaleghi et al. (2017) |
| TT extract | Sperm viability analysis | Viability ↑ * in a dose-dependent manner after 120 minutes of incubation | Origin: YES | [ |
| Determination of DNA fragmentation | No effect on DNA fragmentation of human sperm in vitro | Phytochemical analysis: NO | ||
| Control group: YES | ||||
| Appropriate statistical analysis: YES | ||||
| In Vivo Animal Studies | ||||
| Male adult Sprague Dawley rats, castrated and normal | Sexual behavior studies: MF, IF, ML, IL, EL, PEI | Treatment of castrated rats (with testosterone or TT extract) showed increase in prostate weight and ICP that were statistically significant | Part of the plant: NCS | Gauthaman et al. (2002) |
| TT extract | ICP | Mild to moderate improvement of sexual behavior parameters | Origin: YES | [ |
| Phytochemical analysis: NCS | ||||
| Control group: YES | ||||
| Positive control group: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Male Sprague Dawley rats | ICP | ICP concentration-dependent increase in TT treated group* | Part of the plant: NCS | Kam et al. (2012) |
| TT extract, | cAMP, cGMP in corpus cavernosum | cAMP ↑* in the group treated with the mixture | Origin: YES | [ |
| cGMP no significant difference as compared with the control | Phytochemical analysis: NO | |||
| Control group: YES | ||||
| Positive control group: NO | ||||
| Appropriate statistical analysis: YES | ||||
| -Male rats | Morphometric analysis | Testicular weight ↑* | Origin: YES | Oliveira et al. (2015) |
| TT fruit extract and fractions | Gonadosomatic index | Gonadosomatic index increased in the group supplemented with ethanolic extract | Part of the plant: YES | [ |
| Sperm quality analysis: motility, | -Nuclear, cytoplasmic, and individual volume of Leydig cells increased in supplementation with hexanic and aqueous fractions | Phytochemical analysis: NO | ||
| sperm count, | The extract influenced the spermatogenesis | Control group: YES | ||
| morphology, viability | Positive control group: NO | |||
| Appropriate statistical analysis: YES | ||||
| Male Wistar rats with STZ-induced diabetes (55 mg/kg) | Sperm characteristics, morphology | TT restored antioxidant enzyme activity in testis | Part of the plant: YES | Tag et al. (2015) |
| TT fruit extract | Body and genital organ weight | Improved lipid profile content in serum | Origin: YES | [ |
| Serum testosterone, FSH, LPO level in testicular homogenate | TT treatment decreased testis tubular damage and restored it to normal morphology. | Phytochemical analysis: YES (identification reactions) | ||
| Activity of testicular SOD | Control group: YES | |||
| Testicular CAT activity | Positive control group: YES | |||
| GPx, GST | Appropriate statistical analysis: YES | |||
| Male Wistar rats with STZ-induced diabetes (50 mg/kg) | Testosterone | Sperm motility, sperm count, percentage of sperms with normal morphology ↑* | Part of the plant: YES | Ghanbari et al. (2016) |
| TT seed extract | Sperm analysis: morphology, count and motility | Testosterone ↑* | Origin: NO | [ |
| Phytochemical analysis: NO | ||||
| Control group: YES | ||||
| Positive control group: NO | ||||
| Appropriate statistical analysis: YES | ||||
| Male Sprague Dawley rats | Time to exhaustion of over trained rats | Performance (time to exhaustion) ↑* | Origin: YES | Yin et al. (2016) |
| TT fruit extract (saponins >70%) | Serum testosterone, corticosterone, AR, IGF-1R in liver, gastrocnemius, and soleus | Increase in body weights, relative weights, and protein levels of gastrocnemius | Part of the plant: YES | [ |
| Testosterone ↑* | Phytochemical analysis: YES (UHPLC-Q-TOF/MS) | |||
| AR ↑* | Control group: YES | |||
| IGF-1R ↓# | Appropriate Statistical analysis: YES | |||
| Adult male Swiss albino mice | SOD, CAT, GPx, | SOD, CAT, GST ↓# | Part of the plant: YES | Pavin et al. (2018) |
| TT fruit extract | GR, GST, GSH, 17β-HSD | GPx ↑# | Origin: YES | [ |
| Plasma testosterone | 17β-HSD activity in treated group was not statistically significant different as compared with the control group | Phytochemical analysis: YES (UHPLC-Q-TOF/MS) | ||
| Semen analysis: | Testosterone ↑ | Control group: YES | ||
| motility, vigor, membrane integrity | Motility ↑# | Positive control group: YES | ||
| Histology of testes | No significant modifications in testicular architecture | Appropriate statistical analysis: YES | ||
| Male Wistar rats | Sperm analysis: sperm count, viability, motility | Testosterone, LH ↑* | Part of the plant: YES | Haghmorad |
| TT flower extract and | Serum testosterone, LH, FSH levels | All the treatment groups had higher number of Leydig, spermatogonia and spermatid cells | Origin: YES | et al. (2019) |
| Histological analysis of Leydig and Sertoli cells, spermatogonia, and spermatid cell numbers measure | Phytochemical analysis: NO | [ | ||
| Control group: YES | ||||
| Positive control group: NO | ||||
| Appropriate statistical analysis: YES | ||||
| Sprague Dawley rats with type 2 diabetes induced with high-fat and high-sugar feeding and STZ (30 mg/kg) | ICP, MAP | ICP, ICP/MAP ↑ * | Part of the plant: NCS | Zhang et al. (2019) |
| Gross saponins of TT (GSTT) | eNOS expression level | Nitric oxide ↑* | Origin: YES | [ |
| Nitric oxide level | ROS ↓* | Phytochemical analysis: NCS | ||
| cAMP expression level | No significant difference between the GSTT group and the sildenafil group in increasing cGMP levels | Control group: YES | ||
| ROS levels | Positive control group: YES | |||
| Appropriate statistical analysis: YES | ||||
| Clinical Studies | ||||
| 20–36-Year-old men | Testosterone, androstenedione, LH levels in the serum were measured before and after treatment (24, 72, 240, 408, and 576 h) | No significant difference between TT supplemented groups and the control in the serum testosterone, androstenedione, and LH | Part of the plant: YES | Neychev and Mitev (2005) |
| TT extract | Origin: YES | [ | ||
| Phytochemical analysis or standardization: YES | ||||
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: NCS | ||||
| Appropriate statistical analysis: YES | ||||
| Australian elite male rugby league players | Strength, fat free mass | No significant changes | Part of the plant: NCS | Rogerson et al. (2007) |
| Urinary T/E ratio | No changes in urinary T/E ratio | Origin: YES | [ | |
| Phytochemical analysis or standardization: YES | ||||
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
| 20–22-Year-old athletes | CK, testosterone | CK ↑* | Part of the plant: NCS | Milasius et al. (2009) |
| TT capsules | Anaerobic alactic muscular power | Testosterone ↑* during the first half (10 days) of the experiment | Origin: NCS | [ |
| Anaerobic alactic glycolytic power | Anaerobic alactic muscular power ↑* | Phytochemical analysis or standardization: NCS | ||
| Anaerobic alactic glycolytic power ↑* | Placebo group: YES | |||
| Randomization: NO | ||||
| Double-blind: NO | ||||
| Appropriate statistical analysis: YES | ||||
| Double-blind, randomized trial | IIEF, SQolM, | IIEF ↑* | Part of the plant: NCS | Iacono et al. (2012) |
| Male patients > sixty years with | Testosterone levels after 60 days of treatment, | SQolM ↑* | Origin: NCS | [ |
| reduced libido, with or without erectile dysfunction (ED) | Side effects | TT level increased | Phytochemical analysis or standardization: NCS | |
| Treatment with “Tradamixina”, tadalafil | No side effects (headache, | Placebo group: NO | ||
| nasopharyngitis, | Randomization: YES | |||
| back pain, | Double-blind: YES | |||
| dizziness, | Appropriate statistical analysis: NO | |||
| dyspepsia) were observed | ||||
| Prospective, randomized, double-blind, placebo controlled study | IIEF and serum testosterone were obtained before randomization and after 30 days of study | No effects as compared with the placebo | Part of the plant: NO | Santos et al. (2014) |
| Healthy men, spontaneously complaining of ED, ≥40 years of age | Origin: NO | [ | ||
| TT extract | Phytochemical analysis or standardization: NO | |||
| Placebo group: YES Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Randomized, double-blind, placebo controlled clinical trial study | FSFI score | FSFI ↑* | Part of the plant: YES | Akhtari et al. (2014)[ |
| Women with hypoactive sexual desire disorder | Origin: YES | |||
| TT leaves extract | Phytochemical analysis or standardization: NCS | |||
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Prospective, randomized, double-blind, placebo controlled clinical trial | IIEF score | IIEF score ↑* | Part of the plant: YES | Kamenov et al. (2017) |
| Male with mild to moderate ED | GEQ responses | GEQ responses ↑* | Origin: YES | [ |
| TT product: Tribestan®, | Phytochemical analysis or standardization: YES | |||
| 12-Week treatment period | Placebo group: YES | |||
| Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Single-blind, placebo controlled, parallel study | MRS | Severity of menopausal transition sympt. ↓* | Part of the plant: YES | Fatima and Sultana (2017) |
| Perimenopausal women | Severity of menopausal transition symptoms | MRS ↓* | Origin: YES | [ |
| TT fruit extract | Phytochemical analysis or standardization: NCS | |||
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: NO (single-blind) | ||||
| Appropriate statistical analysis: YES | ||||
| Prospective, randomized, double-blind, placebo controlled trial, | FSFI score | FSFI ↑* | Part of the plant: NCS | Vale et al. (2018) |
| Premenopausal women with diminished libido | QS-F score | QS-F ↑* | Origin: YES | [ |
| TT extract | Serum testosterone | Serum testosterone ↑* | Phytochemical analysis or standardization: NCS | |
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
MF, mount frequency; IF, intromission frequency; ML, mount latency; IL, intromission latency; EL, ejaculation latency; PEI, post-ejaculatory interval; ICP, intracavernous pressure; NCS, not clearly specified; cAMP, adenosine 3′,5′-cyclic monophosphate; cGMP, guanosine 3′,5′-cyclic monophosphate; FSH, follicle-stimulating hormone; LPO, lipid peroxidation; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GST, glutathione; S, transferase; AR, androgen receptor; IGF-1R, insulin growth factor 1 receptor; UHPLC-Q-TOF/MS, ultra-high performance liquid chromatography-quadrupole-time of flight mass spectrometry; GR, glutathione reductase; GSH, glutathione; 17β-HSD, 17β-hydroxysteroid dehydrogenase; LH, luteinizing hormone; MAP, mean arterial pressure; eNOS, endothelial nitric oxide synthase; urinary T/E ratio, urinary testosterone/epitestosterone (T/E) ratio; CK, creatine kinase; ED, erectile dysfunction; IIEF, International Index of Erectile Function; SQoLM, Sexual quality of life questionnaire male; FSFI, Female Sexual Function Index; GEQ, Global Efficacy Question; MRS, menopause rating scale; QS-F, Sexual Quotient Female Version; *, statistically significant difference as compared with the control/placebo; #, statistically significant difference as compared with the positive control group.
Figure 4The presumed mechanism of diosgenin stimulation of PPARγ receptors. PPARγ, peroxisome proliferator-activated receptor gamma; DNA, deoxyribonucleic acid; mRNA, messenger ribonucleic acid; FFA, free fatty acids; GLUT-4, glucose transporter 4; and CD36, cluster of differentiation 36 (fatty acid translocase).
In vitro and in vivo pharmacological studies and the study design evaluation.
| Herbal Drug and Subjects | Assay/Parameters | Outcome of Treated Group | Study Design Evaluation | Reference |
|---|---|---|---|---|
| In Vitro Studies | ||||
| TT fruit extract | α-Glucosidase | Activity inhibition on all tested enzymes | Part of the plant: YES | Lamba et al. (2011) |
| Aldose reductase | Origin: YES | [ | ||
| Phytochemical analysis: NCS | ||||
| Control group: YES | ||||
| Positive control group: YES | ||||
| Appropriate statistical analysis: YES | ||||
| TT seeds | α-Amylase | Concentration- inhibition of enzyme activity | Part of the plant: YES | Ponnusamy et al. (2011) |
| Kinetic studies. | Origin: YES | [ | ||
| Phytochemical analysis: YES (identification reactions, GC/MS) | ||||
| Positive control: YES | ||||
| Appropriate statistical analysis: YES | ||||
| TT leaves | Lipase | Activity inhibition on all tested enzymes | Part of the plant: YES | Ercan and El (2016) |
| α-Amylase | Origin: YES | [ | ||
| α-Glucosidase | Phytochemical analysis: YES (spectrophotometric) | |||
| Positive control: YES | ||||
| Appropriate statistical analysis: YES | ||||
| In Vivo Animal Studies | ||||
| Male Swiss albino rats with STZ-induced diabetes (55 mg/kg) | BW, BG, Hb, HbA1c, TG, TC, HDL, LDL-c | BW ↑* | Part of the plant: YES | El-Tantawy and Hassanin (2007) |
| TT aerial part extract | Histopathological analysis of the pancreas | BG ↓* after 2,4, and 6 h | Origin: YES | [ |
| HbA1c returned to the normal values | Phytochemical analysis: NO | |||
| HDL ↑* | Control group: YES | |||
| TG, TC, LDL-c ↓* | Positive control group: YES | |||
| Histological structure was less affected as compared with the control group | Appropriate statistical analysis: YES | |||
| Wistar rats with STZ-induced diabetes (50 mg/kg) | BG, BW, HbA1c, INS, GLG | BG ↓* | Part of the plant: YES | Lamba et al. (2011) |
| TT fruit extract | Urinary albumin levels | BW ↑* | Origin: YES | [ |
| HbA1c, GLG ↑ | Phytochemical analysis: NCS | |||
| Control group: YES | ||||
| Positive control group: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Male Wistar rats with STZ-induced diabetes (40 mg/kg) | BG | BG, PT, APTT, TC, TG, LDL, ALT, AST, ALP, glucose-6-phosphatas, fructose-1, 6-bisphosphatase, LPO ↓ * | Control group: YES | Kalailingam et al (2014) |
| Diosgenin | HbA1c | HDL, SOD, CAT, GSH ↑ * | Positive control group: NO | [ |
| TC, TG, HDL, LDL, AST, ALP | Appropriate statistical analysis: YES | |||
| PT, APTT | ||||
| Hepatic glucose-6-phosphatase, fructose-1, 6-bisphosphatase SOD, CAT, GSH, LPO | ||||
| Male Sprague Dawley rats with type 2 diabetes induced with high-fat diet (HFD) + STZ (35 mg/kg) | BG, INS, BW | BG ↓ *, INS ↑ *, BW ↑ * | Control group: YES | Tharaheswari et al. (2014) |
| Diosgenin | FFA, TNF-α, IL-6, leptin | FFA, TNF-α, IL-6, leptin ↓ * | Positive control group: NO | [ |
| HOMA-IR, HOMA-B, QUICKI | HOMA-IR, HOMA-B, QUICKI – improved values | Appropriate statistical analysis: YES | ||
| In tissue homogenate were determined: LPO, GSH, SOD, CAT, GPx | Increased adipose tissue mass | |||
| Histopathological analysis of pancreas | Enhanced PPARc expression | |||
| Quantification of adipose PPAR γ | Good interaction of diosgenin with PPAR γ | |||
| Glucose-loaded normal rabbits, | FBG at 30 min, 1, 2, 3 h after dosing | FBG ↓* at 2 hours | Part of the plant: YES | El-Shaibany et al. (2015) |
| TT aerial parts extract | Acute toxicity study | No toxicity | Origin: YES | [ |
| Phytochemical analysis: YES (TLC) | ||||
| Control group: YES | ||||
| Positive control group: YES | ||||
| Appropriate Statistical analysis: YES | ||||
| Male Wistar rats with STZ-induced diabetes (55 mg/kg) | BG | BG ↓* | Part of the plant: YES | Tag et al. (2015) |
| TT fruit extract | INS | INS ↑* | Origin: YES | [ |
| Phytochemical analysis: YES (identification reactions) | ||||
| Control group: YES | ||||
| Positiv control group: YES | ||||
| Appropriate Statistical analysis: YES | ||||
| Sprague Dawley rats with type 2 diabetes induced with high-fat and high-sugar feeding and STZ (30 mg/kg) | BG | BG ↓ | Part of the plant: NO | Zhang et al. (2019) |
| Gross saponins of TT | BW | No significant differences in BW | Origin: YES | [ |
| Phytochemical analysis: NCS | ||||
| Control group: YES | ||||
| Positive control group: YES | ||||
| Appropriate statistical analysis: YES | ||||
| Clinical Studies | ||||
| 100 Patients suffering from DM with microalbuminuria | BG | BG ↓ * | Part of the plant: NCS | Ramteke et al. (2012) |
| Ayurvedic preparation with TT | BP | BP ↓ * | Origin: NCS | [ |
| Urine albumin | Urine albumin ↓* | Phtochemical analysis or standardization: NO | ||
| Placebo group: NO | ||||
| Randomization: YES | ||||
| Double-blind: NCS | ||||
| Appropriate statistical analysis: YES | ||||
| Double-blind randomized placebo controlled clinical trial | FBG, BG 2-hour postprandial HbA1c | BG ↓* | Part of the plant: NCS | Samani et al. (2016)[ |
| Ninety-eight women with diabetes mellitus type 2 | TG, TC, LDL, HDL | TC, LDL ↓* | Origin: YES | |
| TT extract | HbA1c, TG, HDL - no significant differences as compared with the placebo | Phtochemical analysis or standardization: YES | ||
| Placebo group: YES | ||||
| Randomization: YES | ||||
| Double-blind: YES | ||||
| Appropriate statistical analysis: YES | ||||
NCS, not clearly specified; GC/MS, gas chromatography-mass spectrometry; TLC, thin layer chromatography; STZ, streptozotocin; BW, bodyweight; BG, blood glucose; Hb, hemoglobin; HbA1c, glycosylated hemoglobin; TG, serum triglycerides; TC, total cholesterol; HDL, high density lipoprotein; LDL-c, low density lipoprotein cholesterol; INS, insulin; GLG, glycogen; FBG, fasting blood glucose; AST, aspartate aminotransferase; ALP, alkaline phosphatase; PT, prothrombin time; APTT, activated partial thromboplastin time; SOD, superoxide dismutase; CAT, catalase; GSH, glutathione; LPO, lipid peroxidase; FFA, serum free fatty acids; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-B, homeostasis model assessment of β-cell function; QUICKI, quantitative insulin sensitivity check index, PPARγ, peroxisome proliferator-activated receptor gamma; GPx, glutathione peroxidase; BP, blood pressure; *, significant difference as compared with the control group and the placebo group.
Toxicological information of some compounds from the U.S. National Library of Medicine [126].
| Compound | Toxicological Information |
|---|---|
| Diosgenin | Oral LD50 (rat) > 8 g/kg |
| Intraperitoneal LD50 (rat) 4872 mg/kg | |
| Oral LD50 (mouse) > 8 g/kg | |
| Intraperitoneal LD50 (mouse) 3564 mg/kg | |
| Dioscin | Subcutaneous LD50 (mouse) >300 mg/kg |
| Oral TDLo (rat) 1050 mg/kg/1W (intermittent) | |
| Oral TDLo (mouse):400 mg/kg/10D (intermittent) | |
| Tigogenin | Intraperitoneal LDLo (rat):10 mg/kg |
| Harmine | Intramuscular TDLo (man):3 mg/kg |
| Intravenous LDLo (cat) 10 mg/kg | |
| Subcutaneous LDLo (frog) 300 mg/kg | |
| Subcutaneous LD50 (mouse) 243 mg/kg | |
| Intravenous LDLo (mouse) 50 mg/kg | |
| Subcutaneous LD50 (rat) 200 mg/kg | |
| Harmane | Intraperitoneal LD50 (mouse) 50 mg/kg |
| Interperitoneal TDLo (rat) 1 mg/kg | |
| Intraperitoneal LD50 (rabbit) 200 mg/kg | |
| Harmaline | Subcutaneous LD50 (rat) 120 mg/kg |
| Subcutaneous LD50 (mouse) 120 mg/kg | |
| Intraperitoneal TDLo (rat) 4 mg/kg | |
| Norharmane | Oral TDLo (rat) 1050 mg/kg/6W (continuous) |
LD50, median lethal dose; TDLo, lowest published toxic dose; LDLo, lowest lethal dose.